Fabi A, Ciccarese M, Scagnoli S, Russillo M, et al. Post-Progression Treatments after Palbociclib plus Endocrine Therapy in HR+/HER2- Metastatic Breast Cancer Patients: What Is the Better Choice? Oncology 2021 Dec 7. pii: 000521252. doi: 10.1159/000521252.
PMID: 34875670